Key result
A patient with suspected atypical neuroleptic malignant syndrome following rapid conversion of ziprasidone to risperidone successfully responded to antipsychotic cessation, dantrolene, and bromocriptine.
Case Report (n=1)
Early detection and sequential treatment with antipsychotic cessation, dantrolene, and bromocriptine can be effective for atypical neuroleptic malignant syndrome.
No takes yet. Share an insight, caveat, or question.
Rapid antipsychotic conversion without titration may trigger atypical NMS; leaves open whether gradual switches reduce risk in psychiatric patients.
Vickery et al. (2017) conducted a case report in Atypical neuroleptic malignant syndrome (n=1). Antipsychotic cessation and combination therapy with dantrolene and bromocriptine was evaluated on Clinical response. A patient with suspected atypical neuroleptic malignant syndrome following rapid conversion of ziprasidone to risperidone successfully responded to antipsychotic cessation, dantrolene, and bromocriptine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: